126 related articles for article (PubMed ID: 9786483)
1. Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae.
Amyes SG; Thomson CJ
J Antimicrob Chemother; 1998 Sep; 42(3):398-9. PubMed ID: 9786483
[No Abstract] [Full Text] [Related]
2. Quinolones and pneumococci.
Tillotson GS; Peterson LR
J Antimicrob Chemother; 2000 May; 45(5):709-10. PubMed ID: 10797099
[No Abstract] [Full Text] [Related]
3. Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
Niki Y; Tamada S; Nakabayashi M; Soejima R
Drugs; 1995; 49 Suppl 2():420-2. PubMed ID: 8549385
[No Abstract] [Full Text] [Related]
4. Ciprofloxacin vs. the pneumococcus.
Karcic AA; Khan FA
Chest; 2000 Oct; 118(4):1226-7. PubMed ID: 11035706
[No Abstract] [Full Text] [Related]
5. Gemifloxacin: survival of the fittest.
Mandell L
J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():33-7. PubMed ID: 10997597
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolones in chronic obstructive pulmonary disease.
Colville A; Knowles M; Large D; George J; Mustchin P
BMJ; 1994 May; 308(6941):1437. PubMed ID: 8019265
[No Abstract] [Full Text] [Related]
7. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
Simoens S; Verhaegen J; Laekeman G; Peetermans WE
Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
[TBL] [Abstract][Full Text] [Related]
8. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
9. Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.
Johnson AP; Warner M; Parsons T
Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):622-3. PubMed ID: 9323481
[No Abstract] [Full Text] [Related]
10. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD; Low DE
Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
[TBL] [Abstract][Full Text] [Related]
11. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
Hutchinson J
N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102064
[No Abstract] [Full Text] [Related]
12. [Third and fourth generation fluoroquinolones].
Rossi C; Sternon J
Rev Med Brux; 2001 Oct; 22(5):443-56. PubMed ID: 11723788
[TBL] [Abstract][Full Text] [Related]
13. Role of newer fluoroquinolones in lower respiratory tract infections.
Lode H; Allewelt M
J Antimicrob Chemother; 2002 May; 49(5):709-12. PubMed ID: 12003962
[No Abstract] [Full Text] [Related]
14. Susceptibility of streptococcus pneumoniae to fluoroquinolones and macrolides in upper respiratory tract infections.
Mykhalko YO; Duhovych TV; Kish PP
Wiad Lek; 2017; 70(2):224-226. PubMed ID: 28511165
[TBL] [Abstract][Full Text] [Related]
15. [The microbiologist's point of view].
Gutmann L
Presse Med; 2002 Nov; 31(37 Pt 2):S4-5. PubMed ID: 12489324
[No Abstract] [Full Text] [Related]
16. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
Ferrara AM
Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
[TBL] [Abstract][Full Text] [Related]
17. [Resistance of infectious agents involved in low respiratory tract infections in France].
Varon E; Houssaye S
Med Mal Infect; 2006; 36(11-12):555-69. PubMed ID: 16962730
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.
Park HS; Oh SH; Kim HS; Choi DR; Kwak JH
Molecules; 2016 Nov; 21(11):. PubMed ID: 27869677
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections.
Ambrose PG; Grasela DM; Grasela TH; Passarell J; Mayer HB; Pierce PF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2793-7. PubMed ID: 11557471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
